Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
IN |
|
W-Scope Corp
TSE:6619
|
JP |
|
I
|
I Power Solutions India Ltd
BSE:512405
|
IN |
|
Pinnacle West Capital Corp
NYSE:PNW
|
US |
|
M
|
Mad Paws Holdings Ltd
ASX:MPA
|
AU |
|
F I P P SA
PAR:FIPP
|
FR |
|
Broadleaf Co Ltd
TSE:3673
|
JP |
Multiples-Based Value
The Multiples-Based Value for Akums Drugs and Pharmaceuticals Ltd (AKUMS) under the Base Case is hidden INR. Compared with the current market price of 493.35 INR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AKUMS Competitors Multiples
Akums Drugs and Pharmaceuticals Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
75.5B INR | 1.8 | 23.7 | 12.7 | 19.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
975.8B USD | 341.7 | 4 045.6 | 1 159.2 | 2 232.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
183.7B USD | 4.1 | 27.1 | 18.8 | 25.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
135.8B USD | 5.5 | 37.1 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.2B CHF | 5.3 | 36.6 | 27.3 | 27.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
298.3B CNY | 6.6 | 15.6 | 16.2 | 16.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.5B USD | 4.5 | 24.9 | 18.3 | 21.6 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.8B USD | 9.3 | 46 | 29.7 | 37.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29B USD | 1.8 | 21.2 | 11.8 | 17.7 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.4 | 29.5 | 21.9 | 24.3 |